Association between prognosis and the use of angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blocker in frail patients with heart failure with preserved ejection fraction
Event:
ESC Congress 2022
Topic:
Heart Failure with Preserved Ejection Fraction (HFpEF)
Session:
Heart failure with preserved ejection fraction (HFpEF) 1